supp.fit

Fish Oil and Vitamin E: study protocols

17 study groups took Fish Oil together with Vitamin E. These are the doses the studies gave. They are not a recommendation.

Fish Oil: what the research found →

Dose per serving from research: Fish Oil

15 study groups in 12 studies say how much Fish Oil participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 500 mg to 1 g, 33% of 15 study groups.

Daily doseStudy groups
500 mg to 1 g
5
1 g to 2.5 g
3
2.5 g to 5 g
3
5 g to 10 g
1
10 g to 25 g
3

Dose per serving from research: Vitamin E

10 study groups in 7 studies say how much Vitamin E participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 100 mg to 250 mg, 30% of 10 study groups.

Daily doseStudy groups
10 mg or less
1
10 mg to 25 mg
2
25 mg to 50 mg
1
50 mg to 100 mg
2
100 mg to 250 mg
3
250 mg to 500 mg
1

Commonly used together

11 of 17 study groups took Fish Oil and Vitamin E with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Omega-3 Fatty Acids
6
Docosahexaenoic Acid
5
Vitamin C
5
Lutein
3
Zeaxanthin
3

17 study groups

Study
The effects of omega-3 fatty acids on neuropsychological functioning and brain morphology in mid-life adults: a randomized clinical trial
2020 · fish oil group · Adults aged 30–54 years with low dietary EPA and DHA intake and no stated diagnosed condition
2 g10 IU18 weeks134
Wrinkle reduction in post-menopausal women consuming a novel oral supplement: a double-blind placebo-controlled randomized study
2014 · Test group 1 · Healthy, non-smoking post-menopausal women, skin types I–III, not receiving HRT and with BMI 18–33 kg/m²
660 mg250 mg14 weeks55
Wrinkle reduction in post-menopausal women consuming a novel oral supplement: a double-blind placebo-controlled randomized study
2014 · Test group 2 · Healthy, non-smoking post-menopausal women, skin types I–III, not receiving HRT and with BMI 18–33 kg/m²
660 mg30 mg14 weeks55
Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids
2015 · ω-3 PUFA group · People aged 13–25 with ultra-high risk for psychosis
2 g7.6 mg12 weeks40
Omega-3 fatty acid, carotenoid and vitamin E supplementation improves working memory in older adults: A randomised clinical trial
2022 · active group · Cognitively healthy adults aged 65 years and older
1 g15 mg2 years30
Effects of 12-week supplementation of marine Omega-3 PUFA-based formulation Omega3Q10 in older adults with prehypertension and/or elevated blood cholesterol
2017 · Omega3Q10 treatment group · Adults aged at least 50 years with elevated blood pressure and/or elevated blood cholesterol
1 g50 IU12 weeks48
Supplementation With Carotenoids, Omega-3 Fatty Acids, and Vitamin E Has a Positive Effect on the Symptoms and Progression of Alzheimer's Disease
2022 · active group · People with mild-moderate Alzheimer's disease; age and sex not reported
1 g15 mg1 year50
Effects of interaction of RRR-alpha-tocopheryl acetate and fish oil on low-density-lipoprotein oxidation in postmenopausal women with and without hormone-replacement therapy
1996 · 100 mg alpha-tocopheryl acetate daily phase · Postmenopausal women, equally divided between those using and not using hormone-replacement therapy
15 g100 mg5 weeks48
Effects of interaction of RRR-alpha-tocopheryl acetate and fish oil on low-density-lipoprotein oxidation in postmenopausal women with and without hormone-replacement therapy
1996 · 200 mg alpha-tocopheryl acetate daily phase · Postmenopausal women, equally divided between those using and not using hormone-replacement therapy
15 g200 mg5 weeks48
Effects of interaction of RRR-alpha-tocopheryl acetate and fish oil on low-density-lipoprotein oxidation in postmenopausal women with and without hormone-replacement therapy
1996 · 400 mg alpha-tocopheryl acetate daily phase · Postmenopausal women, equally divided between those using and not using hormone-replacement therapy
15 g400 mg5 weeks48
Influence of fish oil supplementation on in vivo and in vitro oxidation resistance of low-density lipoprotein in type 2 diabetes
2003 · Fish oil group · Adults with type 2 diabetes
4 g53.6 mg8 weeks23
Whole blood production of thromboxane, prostacyclin and leukotriene B4 after dietary fish oil supplementation in man: effect of vitamin E
1996 · FO · adult men; no condition stated
30 mL—4 weeks12
Whole blood production of thromboxane, prostacyclin and leukotriene B4 after dietary fish oil supplementation in man: effect of vitamin E
1996 · FO+E · adult men; no condition stated
30 mL—4 weeks12
Encapsulated fish oil enriched in alpha-tocopherol alters plasma phospholipid and mononuclear cell fatty acid compositions but not mononuclear cell functions
2000 · fish oil (FO) · Healthy subjects; age and sex not specified
9 g205 mg12 weeks—
Fish oil and antioxidants alter the composition and function of circulating mononuclear cells in Crohn disease
2004 · fish-oil group · Patients with Crohn disease and raised C-reactive protein concentrations or erythrocyte sedimentation rates; age and sex not stated
2.7 g—24 weeks31
High-dose fish oil and antioxidants in Crohn's disease and the response of bone turnover: a randomised controlled trial
2005 · fish oil plus antioxidants · Patients with Crohn's disease and currently or recently raised biochemical markers of inflammation
2.7 g—24 weeks31
Omega-3 supplementation combined with anti-vascular endothelial growth factor lowers vitreal levels of vascular endothelial growth factor in wet age-related macular degeneration
2014 · Group 1 (Vitalux plus Omega-3) · Adults with active wet age-related macular degeneration who had previously received anti-VEGF treatment
1.05 g400 IU—10
Fish Oil and Vitamin E: study protocols | supp.fit